Chemical synthesis. Related to STAR Methods-Methods Details
Compound 1, 2, 3 and 4 were reported in WO2015054572, and were prepared using similar procedures to those described. 
tert-Butyl 4-(7-bromo-6-chloro-2-((3-ethoxy-3-oxopropyl)amino)-8-fluoroquinazolin-4-yl)piperazine-1-carboxylate
A mixture of tert-butyl 4-(7-bromo-2,6-dichloro-8-fluoroquinazolin-4-yl)piperazine-1-carboxylate (315 mg, 0.66 mmol), ethyl 3-aminopropanoate hydrochloride (301 mg, 1.97 mmol), DIEA (342 uL, 1.97 mmol) in isopropanol (10 mL) was heated to 95 o C for 2 days. Solvent was removed under reduced pressure and the residue was purified by flash chromatography (0-50% ethyl acetate/hexane) to give tert-butyl 4-(7-bromo-6-chloro-2-((3-ethoxy-3-oxopropyl)amino)-8-fluoroquinazolin-4-yl)piperazine-1-carboxylate (290 mg, 79%). 4-(4-Acryloylpiperazin-1-yl)-6-chloro-8-fluoro-7-(2-fluorophenyl)quinazolin-2-yl)amino)-N,N-dimethylpropanamide 
3-((

tert-Butyl
4-(6-chloro-2-((3-(dimethylamino)-3-oxopropyl)amino)-8-fluoro-7-(2-fluorophenyl) quinazolin-4-yl)piperazine-1-carboxylate (10 mg, 0.017 mmol) was treated with 1 mL of TFA/DCM (1:1) for 20 minutes. The solvent was removed and the residue suspended in THF (2 mL) and saturated sodium bicarbonate solution (0.5 mL) and treated with acryloyl chloride (2 uL, 0.025 mmol). The reaction mixture was stirred vigorously for 30 minutes, then the solvent removed and the residue was partitioned between DCM (10 mL) and water (10 mL). The organic layer was washed with brine, dried over sodium sulfate, filtered, concentrated under reduced pressure and dried to give 3-((4-(4-acryloylpiperazin-1-yl)-6-chloro-8-fluoro-7-(2-fluorophenyl)quinazolin-2-yl)amino)-N,N-dimethylpropanamide (6.6 mg, 73 %). 
